Intravenous Nitroglycerin for Retained Placenta Extraction: a Multicenter Study

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Primary objective The primary objective of this study is to see whether intravenous (IV) NTG 100-200 microgram can effectively help extract retained placenta as compared to placebo, in a randomized controlled multicenter study.

Secondary objective is to compare the hypotensive effects of NTG as compared to placebo, including others side effects such as headache, blood loss, or others.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Mahidol University
• Treatments: Nitroglycerin

Criteria

Inclusion Criteria:

• Healthy pregnant patient (ASA classification I ,II )

• Normal pregnancy with at least 28 week gestation

Exclusion Criteria:

• ASA classification III and up

• Having complication of pregnancy such as hypertensive disease of pregnancy,